Grapheal (France)
Vincent Bouchiat is the Founder and CEO of Grapheal, a company spin-off from Neel Institute focusing on bioelectronics and healthcare applications of monolayer graphene. He is on leave from the French National Research Center (CNRS) at Grenoble, where he has a permanent position since 1997. He received an engineer degree from ESPCI-PAris in 1993 and has completed his Ph.D. on quantum devices at CEA-Saclay & Paris University in 1997 under supervision of Michel Devoret
He co-authored more than 110 publications in electron transport in nanodevices with over 6,000 citations and hold 9 international patents. He received the Visiting Miller Professorship Award from University of California, Berkeley in 2007, and the Lee Hsun Research Award from the Chinese Academy of Sciences (2017).
Graphene appears as a very promising material for bioelectronics for both in- vitro and in-vivo sensing applications. Indeed, it combines in the same film biocompatibility (1,2), mechanical flexibility, optical transparency and high mobility Field effect (3). The mass production of Single layer film by CVD on Copper foil has enabled the production of disposable biosensing devices with competitive pricing.
At Grapheal, we have explored the use of graphene-on-polymer for enabling at the same time biosensing and tissue engineering (4) with integration to RFID component to enable direct smartphone connectivity. I will show the application of graphene surface functionalization to implement sensitive and selective biosensors. Finally, I will show prospects for consumer applications that unlock new use cases (5) for wearable and in-vitro diagnostics
[1] A. Bourrier et al. Adv. Health. Mat. 8 , 1801331, (2019) doi : 10.1002/adhm.201801331
[2] F. Veliev, et al., Biomaterials, Elsevier, 86, pp.33−41 (2016).
[3] F. Veliev et al. Doi : 10.3389/fnins.2017.00466 (2017)
[4] Le Gall et al. doi: 10.1101/2021.05.16.444337 (2021)
[5] https://www.grapheal.com
©khalifa university. All rights reserved.
Funded by
